Baseline liver fibrosis severity predicts treatment response in patients with HBeAg-positi
Audio narration · Coming soon
Baseline liver fibrosis severity can predict how well patients with HBeAg-positive chronic hepatitis B respond to treatment with pegylated interferon combined with nucleos(t)ide analogs.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews